MOv19-BBz CAR T Cells in FRa+ Cancers

This trial tests a special type of immune cell therapy called CAR T cells that are engineered to target a protein called folate receptor alpha (FRα), which is found on the surface of certain cancer cells. It is being studied in people with advanced lung cancer or other cancers that express this protein. **You may be eligible if...** - You are 18 or older - Your cancer has been tested and shows folate receptor alpha (FRα) expression on at least 10% of tumor cells - You have metastatic or recurrent lung adenocarcinoma with cancer fluid in the pleural space (around the lung) - You have already received at least one standard treatment for advanced disease - Your organ function (kidneys, liver, heart, lungs) meets minimum requirements **You may NOT be eligible if...** - Your cancer does not express the FRα protein - You have uncontrolled or symptomatic brain metastases - You are on dialysis or have significant liver disease - You are pregnant or breastfeeding Talk to your doctor to see if this trial is right for you.